The 14th Canadian Symposium on Hepatitis C Virus: From research breakthroughs to equitable health care for priority populations
{{output}}
Background: The hepatitis C virus (HCV) affects approximately 214,000 Canadians. While the availability of safe, effective direct-acting antivirals (DAA) has led to decreased rates of chronic HCV infection and increased treatment... ...
